FLVCR2 and hepatocellular carcinoma: It is evident that CCT subunits promote the development of several tumor types, including breast cancer [14,15,16], colorectal cancer [17,18,19], uterine sarcoma [20], lung carcinoma [19], ovarian cancer [21], hepatocellular carcinoma (HCC) [22], and multitudinous tumor cells [23,24].